Acro Biomedical (ACBM) Profit After Tax Growth (3y) (2018 - 2026)
Powered by 
Analysis
Acro Biomedical (ACBM) Profit After Tax Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 10.42% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 1.98% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 59.00% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 6.03% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 50.04% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -34.67% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | -39.51% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | 81.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 81.16% |
| Dec 31, 2025 | 26.22% |
| Sep 30, 2025 | 69.15% |
| Jun 30, 2025 | 84.27% |
| Mar 31, 2025 | 86.21% |
| Dec 31, 2024 | 85.96% |
| Sep 30, 2024 | 84.93% |
| Jun 30, 2024 | 76.63% |
| Mar 31, 2024 | 42.60% |
| Sep 30, 2023 | -179.11% |
| Jun 30, 2023 | -268.81% |
| Mar 31, 2023 | -271.73% |
| Dec 31, 2022 | -272.91% |
| Sep 30, 2022 | -138.49% |
| Jun 30, 2022 | -162.65% |
| Mar 31, 2022 | -184.98% |
| Dec 31, 2021 | -271.71% |
| Sep 30, 2021 | -177.90% |
| Jun 30, 2021 | -106.71% |
| Mar 31, 2021 | -41.89% |